Brit J. Hart
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
Viral Infections and Outbreaks Research, SARS-CoV-2 and COVID-19 Research, Hepatitis B Virus Studies, Genomics and Phylogenetic Studies, Computational Drug Discovery Methods
Most-Cited Works
- → Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection(2014)697 cited
- → Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis(2014)427 cited
- → Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays(2013)214 cited
- → MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells(2018)106 cited
- → Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures(2018)56 cited
- → Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs(2018)52 cited
- → Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus(2016)28 cited
- → In Vitro and In Vivo Activity of Amiodarone Against Ebola Virus(2018)27 cited
- → Interferon-β and Interferon-γ Are Weak Inhibitors of Ebola Virus in Cell-Based Assays(2017)12 cited
- Identification of PTCH1 requirement for influenza virus using random homozygous gene perturbation.(2009)